Alumis (ALMS) Stock Rises Following Strategic Partnership
Following the announcement of a large collaborative deal, Alumis Inc. (NASDAQ: ALMS) shares are enjoying a noteworthy increase today. As of the latest market check, ALMS stock was trading at $9.90, showing a 15.90% rise. The company’s recent alliance with Kaken Pharmaceutical Co., Ltd. is the reason for this upward progress. Partnership to Advance ESK-001 …
Alumis (ALMS) Stock Rises Following Strategic Partnership Read More »